Physician profile
Audra Stanfield
NPI 1447958939
$1,172.74
in general payments reported to CMS, 2019-2025
17 companies · $553 in 2025
The $553 reported for 2025 was more than what 88% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $286 · 2024: $334 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $222.12 | 2024-2025 | Nexplanon |
| Astellas Pharma US INC | $137.48 | 2025 | Veozah |
| Sage Therapeutics, LLC | $114.00 | 2023-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $92.43 | 2023 | |
| Hologic Sales and Service, LLC | $88.20 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $87.42 | 2023-2025 | |
| Abbvie INC. | $81.49 | 2023 | |
| Dexcom, INC. | $81.11 | 2024-2025 | Dexcom G6 Transmitter |
| Millicent US INC | $61.40 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $45.62 | 2025 | |
| Minerva Surgical, INC | $32.97 | 2024 | |
| Sumitomo Pharma America, INC. | $29.44 | 2025 | Myfembree |
| Biogen, INC. | $26.36 | 2024 | Zurzuvae |
| Coopersurgical, INC. | $20.14 | 2025 | Paragard T 380a |
| Supernus Pharmaceuticals, INC. | $19.92 | 2025 | Qelbree |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $18.05 | 2024 | Twirla |
| Avion Pharmaceuticals | $14.59 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audra Stanfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.